Japan Second Committee On Drugs Approves Two New Components Including J&J Hepatitis C Drug Simeprevir
This article was originally published in PharmAsia News
Executive Summary
MHLW Japan’s Second Committee on Drugs deliberated and accepted the approval of two new drugs on Sept 13.